本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Castle Biosciences, Inc.

33.64
+0.20000.60%
成交量:5,441
成交額:18.30萬
市值:10.28億
市盈率:-51.42
高:33.64
開:33.64
低:33.64
收:33.44
52周最高:44.28
52周最低:17.72
股本:3,054.95萬
流通股本:2,821.96萬
量比:10.21
換手率:0.02%
股息:- -
股息率:- -
每股收益(TTM):-0.6542
每股收益(LYR):-0.8334
淨資產收益率:-4.20%
總資產收益率:-1.36%
市淨率:2.19
市盈率(LYR):-40.36

資料載入中...

2025/11/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report
2025/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

重要事件披露

Form 8-K - Current report
2025/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/04

重要事件披露

Form 8-K - Current report
2025/06/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

重要事件披露

Form 8-K - Current report
2025/04/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]